“…5 MICS CABG was popularized in the late 2000s and similarly utilizes a small left anterior thoracotomy, 6 but is differentiated from MIDCAB by its ability to conduct multivessel revascularization without the use of CPB. 7,8 Our group recently reported techniques to harvest BITA under direct vision via a small thoracotomy incision to achieve BITA revascularization in MICS CABG, 9,10 and some centers have successfully undertaken this robotically and endoscopically. 11 In an extreme form, CABG under epidural anesthesia (awake CABG) has been described.…”
To minimize surgical morbidity in coronary artery bypass grafting, minimally invasive cardiac surgery has gained popularity. Minimally invasive coronary artery bypass grafting offers unique advantages compared to conventional off-pump coronary artery bypass or minimally invasive direct coronary artery bypass in that it enables the surgeon to harvest and graft bilateral internal thoracic arteries via a small thoracotomy while being conducted completely off-pump. This review focuses on current evidence behind off-pump coronary artery bypass, multi-arterial revascularization, patient populations that would most benefit from bilateral internal thoracic artery minimally invasive coronary artery bypass grafting, the surgical technique, and early outcomes. By overcoming the perceived inability to utilize bilateral internal thoracic arteries in minimally invasive coronary artery bypass grafting, the new technique further expands the armamentarium of surgeons and cardiologists. Hybrid coronary revascularization with bilateral internal thoracic artery minimally invasive coronary artery bypass grafting further augments the appeal of the next generation of minimally invasive cardiac surgery.
“…5 MICS CABG was popularized in the late 2000s and similarly utilizes a small left anterior thoracotomy, 6 but is differentiated from MIDCAB by its ability to conduct multivessel revascularization without the use of CPB. 7,8 Our group recently reported techniques to harvest BITA under direct vision via a small thoracotomy incision to achieve BITA revascularization in MICS CABG, 9,10 and some centers have successfully undertaken this robotically and endoscopically. 11 In an extreme form, CABG under epidural anesthesia (awake CABG) has been described.…”
To minimize surgical morbidity in coronary artery bypass grafting, minimally invasive cardiac surgery has gained popularity. Minimally invasive coronary artery bypass grafting offers unique advantages compared to conventional off-pump coronary artery bypass or minimally invasive direct coronary artery bypass in that it enables the surgeon to harvest and graft bilateral internal thoracic arteries via a small thoracotomy while being conducted completely off-pump. This review focuses on current evidence behind off-pump coronary artery bypass, multi-arterial revascularization, patient populations that would most benefit from bilateral internal thoracic artery minimally invasive coronary artery bypass grafting, the surgical technique, and early outcomes. By overcoming the perceived inability to utilize bilateral internal thoracic arteries in minimally invasive coronary artery bypass grafting, the new technique further expands the armamentarium of surgeons and cardiologists. Hybrid coronary revascularization with bilateral internal thoracic artery minimally invasive coronary artery bypass grafting further augments the appeal of the next generation of minimally invasive cardiac surgery.
Cardiac surgery is almost universally performed through a median sternotomy, an approach which is painful, unestethical, and prone to life-threatening infections. Minimally invasive cardiac surgery has tried to avoid problems associated with full sternotomy for many years. Recently, uniportal thoracic surgery was shown to be very advantageous when compared to standard thoracotomy and classical video assisted thoracic surgery (VATS). Despite very good results in lung surgery, cardiac surgery through a single thoracic port has rarely been attempted and successfully conducted. The authors present the rational, the technique, and their experience in cardiac single thoracic port surgery (CSTPS).
“…5,6) Furthermore, numerous surgeons consider OPCAB more technically challenging and less cost-effective than the on-pump approach due to more resources being consumed. 7) Therefore, minimally invasive direct coronary artery bypass (MIDCAB) has been suggested as an alternative strategy to address these issues and is currently gaining wide acceptance among clinicians. [7][8][9] Editorial p.457…”
mentioning
confidence: 99%
“…7) Therefore, minimally invasive direct coronary artery bypass (MIDCAB) has been suggested as an alternative strategy to address these issues and is currently gaining wide acceptance among clinicians. [7][8][9] Editorial p.457…”
mentioning
confidence: 99%
“…15) Nevertheless, few patients have received these approaches since significant learning curves, extensive experience, and specialized equipment are required in their application. 7) To develop a safe, effective, and easy-to-perform minimally invasive bypass graft surgery, we have, on the basis of improved devices and our experience with OPCAB, combined lower distal ministernotomy (a partial sternotomy technique) with beating heart surgery techniques to develop a novel approach (TM-OPCAB) for patients with triple-vessel diseases. The aim of this study is to provide evidence for the feasibility and safety of this technique in the treatment of triplevessel diseases through a retrospective comparison between patients receiving TM-OPCAB and standard OP-CAB surgery (S-OPCAB).…”
We have developed off-pump coronary artery bypass approach with lower distal mini-sternotomy (TM-OPCAB) for multivessel coronary revascularization. The aim of this retrospective study is to provide evidence for the feasibility and safety of this technique in the treatment of triple-vessel diseases.Two hundred eighty-eight patients with triple-vessel coronary artery disease who underwent TM-OPCAB or standard off-pump coronary artery bypass surgery (S-OPCAB) were included in this study after propensity-score matching. We retrospectively reviewed the clinical data of all patients and compared their demographic data, intra- and perioperative details, as well as short-term and long-term outcomes.TM-OPCAB resulted in significantly shorter periods of time on ventilation (P = 0.0222), shorter postoperative in-hospital stays (P < 0.0001), and lower blood transfusion rates (P = 0.0013) than S-OPCAB. Transit-time flow measurement showed there was no significant difference in postoperative graft patency between both groups. Within the 30-day post-surgical period, no death or occurrence of stroke was observed in patients undergoing TM-OPCAB or S-OPCAB. After an average of 35 months of follow-up, Kaplan-Meier survival analysis indicated that overall survival and the percentage of patients freed from major adverse cardiac and cerebrovascular events were similar between both groups. Additionally, the rate of repeat revascularization was slightly lower in the TM-OPCAB group (1.4%) than in the S-OPCAB group (2.2%), although there was no statistical difference noted.Our findings suggest that TM-OPCAB is technically feasible and safe for use in revascularization procedures in patients with triple-vessel diseases.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.